21 results
Thumbnail

D1.13 - A rare case of isolated histaminergic angioedema

Thumbnail

D1.15 - True Mugwort Sensitization Presenting as Severe Atopic Dermatitis: A Diagnostic Challenge

Thumbnail

D1.02 - Sensitization to Sesame Proteins Despite Negative Conventional Testing

Thumbnail

D1.03 - Identification of a Thaumatin-Like Protein as a Shared Allergen in Kiwi and Persimmon: Molecular Analysis in a Case of Anaphylaxis

Thumbnail

D1.08 - Clinical relevance of troponin C (Cra c 6) sensitization in crustacean allergy

Thumbnail

D1.10 - Underrecognition of Anaphylaxis in Children: Gaps in Diagnosis and Management

Thumbnail

D1.11 - Determinants of allergen sensitization and wheal size variability in skin prick testing in a large outpatient cohort

Thumbnail

D1.14 - Biphasic, Refractory, and Persistent Anaphylaxis in Children

Thumbnail

D1.06 - When an alergic reaction turns into a cardiac event: clinical characterization of Kounis Syndrome

Thumbnail

D1.284 - Eosinophilic Esophagitis Before and After Milk Oral Immunotherapy in Children with Food Allergy: A Case Series Including the Eosinophil-to-Lymphocyte Ratio

Thumbnail

D1.283 - Endolysosomal degradation of major peanut allergens revealed distinct degradation kinetics and T cell epitope regions

Thumbnail

D1.286 - Allergenic Protein Profiling in a Patient with Long-standing Nut-Induced Anaphylaxis

Thumbnail

D1.287 - Polysensitization to Seed Storage Proteins, LTPs and Profilin in a Patient With Anaphylaxis After Consumption of Pesto Sauce

Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis

Thumbnail

D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial

Thumbnail

D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to